
Jason Williams, MD, discusses the development of intratumoral immunotherapy, as well as trial results from his poster presentation at the 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019).
Your AI-Trained Oncology Knowledge Connection!
Published: November 12th 2019 | Updated: